Cardiol Therapeutics Inc. (‘Cardiol' or the ‘Company') announced that its Board of Directors has appointed Jennifer M. Chao to serve as a director, effective immediately. Ms. Chao has also been appointed Chair of the Corporate Governance and Compensation Committee. Ms. Chao has over 25 years of experience in the biotech and life sciences industries focused primarily on finance and corporate strategy.

She is Managing Partner of CoreStrategies Management, LLC. She currently serves on the Board of Directors of Endo Pharmaceuticals and is a member of the Audit Committee and Compliance Committee. Iain Chalmers has stepped down from the Board of Directors to accommodate Ms. Chao's appointment.